Akaza Research announces that it has completed a comprehensive onsite training for the Kemri-Wellcome Research Programme for using the OpenClinica Enterprise platform for its clinical research activities in Kenya.
KEMRI-Wellcome Research Programme in Kenya Trained on OpenClinica
(Kilifi, Kenya) July 5, 2007 – Akaza Research, the leading provider of OpenClinica clinical software, announces that it has completed a comprehensive onsite training for the KEMRI-Wellcome Research Programme for using the OpenClinica Enterprise platform for its clinical research activities in Kenya.
Every day more than 2500 people around the World die of malaria, most of them children. The Wellcome-KEMRI (Kenya Medical Research Institute) Research Programme is working to accelerate high-quality research towards effective treatments of malaria and other important infectious diseases.
About the KEMRI-Wellcome Research Programme
The KEMRI-Wellcome Research Programme is a collaboration between the UK-based Wellcome Trust and KEMRI (the Kenyan Medical Research Institute) to help safeguard the health of young African children. With a long-standing commitment to scientific capacity strengthening, it has established itself as an internationally renowned research centre tackling malaria and other important infectious diseases. The Programme is located at sites in Kilifi and in Kenya’s capital Nairobi. For more information see http://www.kemri-wellcome.org.
OpenClinica is an open source, web-based software platform for managing clinical research. It facilitates protocol configuration, design of case report forms, electronic data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a strictly standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at www.OpenClinica.org.
About Akaza Research
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data collection and management software platform. Akaza brings Open Source Software solutions into the mainstream of the clinical research enterprise by making high quality, standards-based systems accessible for private and public research. Akaza Research provides support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.